Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, ...

Kimberly-Clark said Monday it would acquire Kenvue for more than $40 billion in cash and stock, creating a consumer ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

The announcement comes weeks after President Trump made claims linking Tylenol to autism in pregnant women's unborn babies, ...

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

Shareholders of Kimberly-Clark will own about 54% of the combined company. Two years ago, Johnson & Johnson spun off its ...

What company makes Tylenol? Kimberly-Clark buys Kenvue in massive billion-dollar deal. Here's the who and what to know about ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...